STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’

Summary

Article discusses how blockbuster GLP-1 drugs have evolved from prescription medications for patients to lifestyle drugs marketed as consumer products, reflecting a shift in how these obesity medicines are being positioned and sold.